Research & Development (R&D) activities of «Grindeks» are focused on the fulfilment of the yet unachieved pharmaceutical needs. Our goal is to create innovative brand products that could be used for the fulfilment of health care needs in the future.
Every year company allocates significant resources (8-10% of the net sales) in the research and development that are mainly oriented towards following fields – development of cardio vascular, neurological, anti cancer and virus preparations. 4-5 research projects are carried out annually and about 70 employees are involved in the R&D activities of the company.
Currently «Grindeks» is the holder of significant patents in different countries of the world, and company is planning to register numerous new patents.